Epstein-barr virus and B cell survival
- 1 December 1992
- journal article
- forum
- Published by Wiley in Reviews in Medical Virology
- Vol. 2 (4) , 205-220
- https://doi.org/10.1002/rmv.1980020405
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- CD21 is a ligand for CD23 and regulates IgE productionNature, 1992
- Interleukin-5 is an autocrine growth factor for Epstein-Barr virus- transformed B lymphocytesBlood, 1992
- Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6Blood, 1992
- Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.Proceedings of the National Academy of Sciences, 1991
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- Epstein-Barr Virus-Associated Lymphoproliferative Disorders in Immunocompromised IndividualsAdvances in Cancer Research, 1991
- Autocrine Regulation of Normal and Malignant B LymphocytesAdvances in Cancer Research, 1991
- Different Epstein--Barr virus--B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell lineJournal of General Virology, 1990
- Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.Proceedings of the National Academy of Sciences, 1987
- Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germline or rearranged but nonexpressed heavy chain genesEuropean Journal of Immunology, 1987